business
FDA Panel Recommends Approval Of GRAIL's Galleri Multi-Cancer Early Detection Test
GRAIL Inc.'s (GRAL) Galleri multi-cancer early detection test has received a favorable vote from the FDA panel, making it one step closer to approval. The FDA's final decision on Galleri is expected in the coming months.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
US stocks: S&P 500 ends nearly flat as US-Iran talks help stocks pare losses
economictimes.indiatimes.com
McDonald’s offers US$8.5 billion to help owners with overhaul
financialpost.com
Carney tells NYT he looked at ‘extreme tail risk’ of U.S. invasion
financialpost.com
Former VC Partner Hsin-Ju Chuang Dies at 37: What We Know So far
Cryptonews
Form 8.5 (EPT/RI)-Pollen Street Group Limited
Globenewswire_fr